Erschienen in:
01.09.2004 | Oral presentation
Autoantibodies and cognitive impairment in systemic lupus erythematosus
verfasst von:
C Kowal, L DeGiorgio, P Huerta, H Hetherington, B Volpe, B Diamond
Erschienen in:
Arthritis Research & Therapy
|
Sonderheft 3/2004
Einloggen, um Zugang zu erhalten
Excerpt
Many patients with systemic lupus erythematosus experience cognitive decline as their disease progresses. The pathogenic mechanisms include thrombosis, vasculitis, and drug toxicity. We have demonstrated that a subset of anti-DNA antibodies cross-reacts with N-methyl-D-aspartate NMDA receptors and can cause excitotoxic cell death. In mice with high serum titers of these antibodies, there is no evidence of brain damage until there is a breach in the blood–brain barrier. With a break in the blood–brain barrier induced by administration of lipopolysaccharide, the antibodies bind preferentially to hippocampal neurons that express N-methyl-D-aspartate receptors at high density. The antibodies mediate a noninflammatory apoptotic cell death. By 1 week following lipopolysaccharide administration, there is a 30% loss of hippocampal neurons. At 1 month there is no further loss of neurons, suggesting that the blood–brain barrier closes and the antibodies have no further access to brain tissue. …